"Fatty Alcohols" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Usually high-molecular-weight, straight-chain primary alcohols, but can also range from as few as 4 carbons, derived from natural fats and oils, including lauryl, stearyl, oleyl, and linoleyl alcohols. They are used in pharmaceuticals, cosmetics, detergents, plastics, and lube oils and in textile manufacture. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed)
Below are MeSH descriptors whose meaning is more general than "Fatty Alcohols".
Below are MeSH descriptors whose meaning is more specific than "Fatty Alcohols".
This graph shows the total number of publications written about "Fatty Alcohols" by people in this website by year, and whether "Fatty Alcohols" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
|Year||Major Topic||Minor Topic||Total|
To return to the timeline, click here.
Below are the most recent publications written about "Fatty Alcohols" by people in Profiles.
Falcarindiol and dichloromethane fraction are bioactive components in Oplopanax elatus: Colorectal cancer chemoprevention via induction of apoptosis and G2/M cell cycle arrest mediated by cyclin A upregulation. J Appl Biomed. 2021; 19(2):113-124.
Identification of potential anticancer compounds from Oplopanax horridus. Phytomedicine. 2013 Aug 15; 20(11):999-1006.
Fenugreek extract as an inducer of cellular death via autophagy in human T lymphoma Jurkat cells. BMC Complement Altern Med. 2012 Oct 30; 12:202.
The antitumor natural compound falcarindiol promotes cancer cell death by inducing endoplasmic reticulum stress. Cell Death Dis. 2012 Aug 23; 3:e376.
Cholesterol displacement from membrane phospholipids by hexadecanol. Biophys J. 2007 Sep 15; 93(6):2038-47.
Clinical efficacy of topical docosanol 10% cream for herpes simplex labialis: A multicenter, randomized, placebo-controlled trial. J Am Acad Dermatol. 2001 Aug; 45(2):222-30.